Global Heparin Supply, Demand and Key Producers, 2026-2032
Description
The global Heparin market size is expected to reach $ 2508 million by 2032, rising at a market growth of 7.6% CAGR during the forecast period (2026-2032).
In 2024, global Heparin production reached approximately 23,498 billion units , with an average global market price of around US$ 52,147 per billion units. Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the Heparin API.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
The heparin API market is primarily driven by the rising global prevalence of cardiovascular and thromboembolic diseases, along with increasing surgical procedures. Growing aging populations and higher obesity rates contribute to sustained demand for anticoagulants. Additionally, heparin's use in treating COVID-19-associated thrombotic complications has further propelled market expansion. Pharmaceutical industry advancements in emerging markets (e.g., China and India) and the biopharmaceutical sector's demand for high-quality heparin also fuel market growth.
Key trends in the heparin API market include: 1) a technological shift from animal-sourced heparin (porcine intestinal mucosa extraction) to synthetic alternatives (e.g., low-molecular-weight heparin); 2) stringent regulatory requirements for supply chain traceability and quality control; 3) intensified competition from biosimilars, driving process optimization and cost reduction; and 4) the rise of local pharmaceutical players in emerging markets, diversifying the global heparin supply chain.
This report studies the global Heparin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Heparin and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Heparin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Heparin total production and demand, 2021-2032, (billion units)
Global Heparin total production value, 2021-2032, (USD Million)
Global Heparin production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (billion units), (based on production site)
Global Heparin consumption by region & country, CAGR, 2021-2032 & (billion units)
U.S. VS China: Heparin domestic production, consumption, key domestic manufacturers and share
Global Heparin production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (billion units)
Global Heparin production by Type, production, value, CAGR, 2021-2032, (USD Million) & (billion units)
Global Heparin production by Application, production, value, CAGR, 2021-2032, (USD Million) & (billion units)
This report profiles key players in the global Heparin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioibérica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Heparin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (billion units) and average price (US$/billion units) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Heparin Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Heparin Market, Segmentation by Type:
Heparin Sodium
Heparin Calcium
Global Heparin Market, Segmentation by Application:
UFH
LMWH
Companies Profiled:
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Key Questions Answered:
1. How big is the global Heparin market?
2. What is the demand of the global Heparin market?
3. What is the year over year growth of the global Heparin market?
4. What is the production and production value of the global Heparin market?
5. Who are the key producers in the global Heparin market?
6. What are the growth factors driving the market demand?
In 2024, global Heparin production reached approximately 23,498 billion units , with an average global market price of around US$ 52,147 per billion units. Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the Heparin API.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
The heparin API market is primarily driven by the rising global prevalence of cardiovascular and thromboembolic diseases, along with increasing surgical procedures. Growing aging populations and higher obesity rates contribute to sustained demand for anticoagulants. Additionally, heparin's use in treating COVID-19-associated thrombotic complications has further propelled market expansion. Pharmaceutical industry advancements in emerging markets (e.g., China and India) and the biopharmaceutical sector's demand for high-quality heparin also fuel market growth.
Key trends in the heparin API market include: 1) a technological shift from animal-sourced heparin (porcine intestinal mucosa extraction) to synthetic alternatives (e.g., low-molecular-weight heparin); 2) stringent regulatory requirements for supply chain traceability and quality control; 3) intensified competition from biosimilars, driving process optimization and cost reduction; and 4) the rise of local pharmaceutical players in emerging markets, diversifying the global heparin supply chain.
This report studies the global Heparin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Heparin and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Heparin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Heparin total production and demand, 2021-2032, (billion units)
Global Heparin total production value, 2021-2032, (USD Million)
Global Heparin production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (billion units), (based on production site)
Global Heparin consumption by region & country, CAGR, 2021-2032 & (billion units)
U.S. VS China: Heparin domestic production, consumption, key domestic manufacturers and share
Global Heparin production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (billion units)
Global Heparin production by Type, production, value, CAGR, 2021-2032, (USD Million) & (billion units)
Global Heparin production by Application, production, value, CAGR, 2021-2032, (USD Million) & (billion units)
This report profiles key players in the global Heparin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioibérica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Heparin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (billion units) and average price (US$/billion units) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Heparin Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Heparin Market, Segmentation by Type:
Heparin Sodium
Heparin Calcium
Global Heparin Market, Segmentation by Application:
UFH
LMWH
Companies Profiled:
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Key Questions Answered:
1. How big is the global Heparin market?
2. What is the demand of the global Heparin market?
3. What is the year over year growth of the global Heparin market?
4. What is the production and production value of the global Heparin market?
5. Who are the key producers in the global Heparin market?
6. What are the growth factors driving the market demand?
Table of Contents
116 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
